These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19264779)

  • 1. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.
    Kinpara S; Hasegawa A; Utsunomiya A; Nishitsuji H; Furukawa H; Masuda T; Kannagi M
    J Virol; 2009 May; 83(10):5101-8. PubMed ID: 19264779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.
    Kinpara S; Kijiyama M; Takamori A; Hasegawa A; Sasada A; Masuda T; Tanaka Y; Utsunomiya A; Kannagi M
    Retrovirology; 2013 May; 10():52. PubMed ID: 23688327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
    Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
    J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IL-10- and IFN-gamma-producing T-cell responses by autoreactive T-cells expressing human T-cell leukemia virus type I Tax.
    Takatsuka N; Hasegawa A; Takamori A; Shimizu Y; Kato H; Ohashi T; Amagasa T; Masuda T; Kannagi M
    Int Immunol; 2009 Sep; 21(9):1089-100. PubMed ID: 19654198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
    Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to HTLV-I(ACH) during acute infection of pig-tailed macaques.
    McGinn TM; Wei Q; Stallworth J; Fultz PN
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):443-56. PubMed ID: 15157363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
    Sawada L; Nagano Y; Hasegawa A; Kanai H; Nogami K; Ito S; Sato T; Yamano Y; Tanaka Y; Masuda T; Kannagi M
    PLoS Pathog; 2017 Sep; 13(9):e1006597. PubMed ID: 28910419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free entry of human T-cell leukemia virus type 1 to mouse cells.
    Feng R; Kabayama A; Uchida K; Hoshino H; Miwa M
    Jpn J Cancer Res; 2001 Apr; 92(4):410-6. PubMed ID: 11346463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.
    Narulla MS; Alsairi A; Charmier L; Noonan S; Conroy D; Hall WW; Sheehy N
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity.
    Kannagi M; Hasegawa A; Kinpara S; Shimizu Y; Takamori A; Utsunomiya A
    Cancer Sci; 2011 Apr; 102(4):670-6. PubMed ID: 21219540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
    Zimmerman B; Niewiesk S; Lairmore MD
    Vet Pathol; 2010 Jul; 47(4):677-89. PubMed ID: 20442421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo dynamics and adaptation of HTLV-1-infected clones under different clinical conditions.
    Izaki M; Yasunaga JI; Nosaka K; Sugata K; Utsunomiya H; Suehiro Y; Shichijo T; Yamada A; Sugawara Y; Hibi T; Inomata Y; Akari H; Melamed A; Bangham C; Matsuoka M
    PLoS Pathog; 2021 Feb; 17(2):e1009271. PubMed ID: 33524072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.
    Kannagi M; Hasegawa A; Takamori A; Kinpara S; Utsunomiya A
    Front Microbiol; 2012; 3():323. PubMed ID: 22969761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor immunity against adult T-cell leukemia.
    Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
    Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.